x

Search for a diagnostic test

* (*) mandatory field

25 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Bayern
MÜNCHEN

Accreditation
HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation
Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Molecular diagnosis of narcolepsy (HCRT gene)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technical procedure(s) : Sanger sequencing

FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation
Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
IVRY SUR SEINE

Accreditation
Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1)
Biomnis
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

GERMANY

Nordrhein-Westfalen
BAD OEYNHAUSEN

Accreditation
Analysis of susceptibility for narcolepsy (HLA-DQ, HLA-DR)
Ruhr-Universität Bochum
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater London
LONDON

Accreditation
Analysis of susceptibility for narcolepsy (HLA-DQB1*15, HLA-DRB1*06)
The Doctors Laboratory Ltd
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

RHONE-ALPES
LYON

Accreditation
Molecular diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes)
EFS Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

SWITZERLAND

Suisse Romande
GENÈVE

Accreditation
Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

FRANCE

RHONE-ALPES
LA TRONCHE

Accreditation
Molecular diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes: PCR-SSO)
EFS Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

BRETAGNE
RENNES

Accreditation
Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 )
EFS Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technical procedure(s) : NGS sequencing (except WES)

SWITZERLAND

Suisse Alémanique
SCHLIEREN

Molecular diagnosis of Narcolepsy: complete sequencing of HCRT gene
Universität Zürich
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region

SPAIN

Comunidad Valenciana
PATERNA

Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (haplotypes DQB1*0602+DRB1*1501)
IMEGEN - Instituto de Medicina Genómica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

GERMANY

Sachsen
DRESDEN

Analysis of susceptibility for narcolepsy (HLA-DQB1, HCRT, MOG genes)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

ITALY

LAZIO
ROMA

Molecular diagnosis of suceptibility to narcolepsy (HLA-DQA1, HLA-DQB1 genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

TOSCANA
PRATO

Molecular diagnosis of susceptibility to narcolepsy (HAL-DQB1 gene)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Molecular diagnosis of susceptibility to narcolepsy (HLA-DQB1 gene)
Établissement Français du Sang Alpes-Méditerranée
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

PORTUGAL

CENTRO
OEIRAS

Analysis of susceptibility for Narcolepsy-cataplexy and Narcolepsy without cataplexy (HLA-DQB1 and HLA-DRB1 gene)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene ; PCR-SSO)
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

CHAMPAGNE-ARDENNE
REIMS

Diagnosis of predisposition to narcolepsy-cataplexy (HLA-DQB1*06:02 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Molecular diagnosis of susceptibilty to narcolepsy with cataplexy (HLA-DQB1 gene)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

GERMANY

Hessen
GIEßEN

HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
Humangenetische Praxis Dr. Schmidt & Mautner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Molecular diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 and HLA-DRB1 genotyping)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technical procedure(s) : PCR based techniques

FRANCE

AQUITAINE
BORDEAUX

Molecular diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technical procedure(s) : PCR based techniques